#4677
Anonymous

    Can you please comment the study that led to the label change for nivolumab monotherapy for metastatic/unresectable from 60 to 30 minutes infusion time? Do you think the label will also change for the adjuvant setting (Which is currently still 60 minutes)?

    Latest Activity